Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Income from Non-Controlling Interests (2016 - 2025)

Marimed has reported Income from Non-Controlling Interests over the past 10 years, most recently at -$10000.0 for Q4 2025.

  • Quarterly Income from Non-Controlling Interests fell 433.33% to -$10000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28000.0 through Dec 2025, down 24.32% year-over-year, with the annual reading at $28000.0 for FY2025, 24.32% down from the prior year.
  • Income from Non-Controlling Interests was -$10000.0 for Q4 2025 at Marimed, down from $7000.0 in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $110000.0 in Q4 2021 and troughed at -$19000.0 in Q1 2023.
  • The 5-year median for Income from Non-Controlling Interests is $16000.0 (2022), against an average of $31700.0.
  • Year-over-year, Income from Non-Controlling Interests soared 650.0% in 2023 and then crashed 433.33% in 2025.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $110000.0 in 2021, then plummeted by 96.36% to $4000.0 in 2022, then soared by 650.0% to $30000.0 in 2023, then plummeted by 90.0% to $3000.0 in 2024, then crashed by 433.33% to -$10000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Income from Non-Controlling Interests are -$10000.0 (Q4 2025), $7000.0 (Q3 2025), and -$1000.0 (Q2 2025).